Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1146 results for "usfda"

Glenmark Pharma gets USFDA nod for anti-fungal ointment
Money Control

USFDA approval for Glenmark Pharma's ant-fungal ointment

The company's current portfolio consists of 111 products authorised for distribution in the US marketplace. Glenmark Pharmaceuticals Tuesday said it has received final approval from the US health regulator for anti-fungal ointment nystatin and ... Indian Express, 1 day ago

269 images for usfda

Money Control, 1 day ago
DNA, 1 day ago
Money Control, 1 week ago
Deccan Chronicle, 2 weeks ago
Money Control, 1 week ago
Money Control, 2 weeks ago
India Infoline, 1 week ago
India Infoline, 1 week ago, 3 weeks ago
Financial Express, 1 week ago
India Infoline

Shriram EPC bagged Rs 0.61bn contract and top corporate news of the day

Granules India said its Gagillapur facility in Hyderabad has completed USFDA inspection without any observations. (BL) Ashok Leyland launched Circuit Series firstElectricBusMade in India. (BS) IFCI lowered short-term lending rate by a steep ...
 India Infoline1 week ago Granules Hyderabad plant completes USFDA inspection  Business Line1 week ago Granules Hyderabad plant successfully closes USFDA inspection  Business Standard1 week ago Inox Wind bagged repeat orders from the Malpani Group and top corporate news of the day  India Infoline1 week ago

USFDA inspection at Granules unit ends

Granules India facility at Gagillapur, Hyderabad, has successfully completed an inspection by the US Food and Drug Administration. The inspection had been completed without any observations, the company said in a regulatory filing on Monday. It did ...
 The Hindu1 week ago Granules up 5% after Gagillapur unit completes USFDA inspection  Money Control1 week ago
India Infoline

Resonance Specialties jumps 4% after USFDA inspects its manufacturing site in Bhopal

Infoline News Service | Mumbai | October 17, 2016, 14:27 IST One of the company’s manufacturing sites - Vista Organics, Mandideep, (Bhopal) has been recently inspected by the USFDA. No 483 observations have been issued and EIR is awaited by the company.
 India Infoline1 week ago Resonance up 5% as USFDA reports no observations for Bhopal unit  Money Control1 week ago Resonance Specialties Ltd's arm gets USFDA approval  Equity Bulls1 week ago USFDA inspects Mandideep facility of Resonance Specialties  Money Control1 week ago

Cipla receives EIR from USFDA for Indore facility

 Myiris1 week ago Cipla receives EIR for its Indore facility  Business Standard1 week ago Cipla climbs 3% on receiving EIR from USFDA  Economic Times1 week ago BRIEF-Cipla gets EIR from USFDA for its Indore facility  Reuters UK2 weeks ago
Money Control

Granules India intimates of successful USFDA inspection of Gagillapur facility

This page uses frames, but your browser doesn't
 Capital Market1 week ago Granules Indias Gagillapur unit successfully completed USFDA inspection  India Infoline1 week ago BRIEF-Granules India's Gagillapur facility successfully completes USFDA inspection  Reuters UK1 week ago Resonance Specialties provides update on USFDA inspection  Capital Market1 week ago

Marksans Pharma soars 4% on USFDA approval for Paricalcitol drug

Marksans Pharma shares gained 4 percent intraday Monday after the company has received approval from the US health regulator for Paricalcitol capsules.
 Money Control1 week ago Aurobindo, Shilpa Medicare shares gain on USFDA approvals  Money Control3 weeks ago Jubilant Life Sciences shares rise after USFDA approves new medicine  Livemint.com3 weeks ago Jubilant Life Sciences hits 52-week high on USFDA approval for RUBY-FILL  Economic Times3 weeks ago

Granules India gains as USFDA completes inspection at Gagillapur facility

Granules India rose 1.29% to Rs 121.55 at 12:16 IST on BSE after the company's Gagillapur facility, Hyderabad successfully completed USFDA inspection without any observations.
 Business Standard1 week ago
Money Control

Cipla spurts on receiving Establishment Inspection Report from USFDA for Indore facility

The article below represents a preview only and is not meant for reuse or republishing. India, Oct. 13 -- Cipla is currently trading at Rs. 590.15, up by 9.60 points or 1.65% from its previous closing of Rs 580.55 on the BSE. The scrip opened at ...
 HT Syndication1 week ago Cipla receives EIR Report from USFDA for Indore facility  Business Standard2 weeks ago Alembic Pharma Surges 6%, Gets Inspection Report From USFDA  NDTV3 weeks ago Alembic Pharma receives inspection report from USFDA; shares up 3.7%  DNA3 weeks ago
Money Control

Scottish Company Receives USFDA Warning Letter

Wallace Cameron International was cited for not registering its Wishaw, Scotland facility with FDA. FDA issued a warning letter , dated Sept. 29, 2016, to Wallace Cameron International regarding drugs shipped to the United States from the ...
 BioPharm International4 days ago Dr. Reddy's Laboratories launch Aripiprazole tablets to treat schizophrenia, in US  The American Bazaar1 week ago USFDA issues warning letter to Unimark Remedies  Money Control2 months ago USFDA issues warning letter to ex-Sun Pharma US facility  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - usfda
Get updated on latest news & your favorite topics right in your inbox!
More     Less